Comparison of body mass index and metabolic parameters with serum vaspin levels in women with polycystic ovary syndrome
- 29 January 2020
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (2), 137-139
- https://doi.org/10.1016/j.dsx.2020.01.008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMIGynecological Endocrinology, 2012
- Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndromeGynecological Endocrinology, 2010
- The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndromeObesity Reviews, 2009
- Metformin Decreases the Adipokine Vaspin in Overweight Women With Polycystic Ovary Syndrome Concomitant With Improvement in Insulin Sensitivity and a Decrease in Insulin ResistanceDiabetes, 2008
- Vaspin: a novel serpin with insulin-sensitizing effectsExpert Opinion on Investigational Drugs, 2008
- Serum Vaspin Concentrations in Human Obesity and Type 2 DiabetesDiabetes, 2008
- Vaspin gene expression in human adipose tissue: Association with obesity and type 2 diabetesBiochemical and Biophysical Research Communications, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985